Dextrocardia With Isomorphism

Overview

• Definition: Dextrocardia with isomorphism refers to a rare congenital anomaly characterized by the principal mass of the heart being located in the right hemithorax (dextrocardia) accompanied by situs ambiguous with isomerism, where the visceral organs and atria/lungs exhibit bilateral symmetry. Isomerism (or situs ambiguus) means that neither the usual right-sided nor left-sided asymmetry is present, but rather a "mirror image" or duplication of either the right-sided or left-sided structures. This often results in complex congenital heart disease. Isomerism can be further divided into right atrial isomerism (asplenia syndrome) and left atrial isomerism (polysplenia syndrome).
• Epidemiology: The exact incidence of dextrocardia specifically with isomerism is difficult to ascertain, as it is a subset of situs ambiguus. Situs ambiguus occurs in approximately 1 in 10,000 to 1 in 20,000 live births. Dextrocardia itself occurs in approximately 1 in 12,000 pregnancies. Isomerism is strongly associated with complex congenital heart disease, occurring in 90-100% of cases. Right atrial isomerism (RAI) is less common than left atrial isomerism (LAI) but is associated with more severe cardiac anomalies.
• Classification:
  • Dextrocardia with Right Atrial Isomerism (RAI) / Asplenia Syndrome:
    • Bilateral right-sidedness: Both atria have morphological right atrial features (e.g., broad, triangular atrial appendages).
    • Both lungs are trilobed.
    • Short bronchi on both sides.
    • Aplasia or hypoplasia of the spleen (asplenia).
    • Associated with complex cyanotic congenital heart disease (e.g., common atrium, complete atrioventricular septal defect, transposition of the great arteries, pulmonary stenosis or atresia, anomalous systemic venous return, anomalous pulmonary venous return).
    • Hepatic inferior vena cava (IVC) may be positioned centrally.
    • Gallbladder malformations.
  • Dextrocardia with Left Atrial Isomerism (LAI) / Polysplenia Syndrome:
    • Bilateral left-sidedness: Both atria have morphological left atrial features (e.g., long, narrow, finger-like atrial appendages).
    • Both lungs are bilobed.
    • Long bronchi on both sides.
    • Multiple small spleens (polysplenia) or a single rudimentary spleen.
    • Associated with less severe, often acyanotic to mildly cyanotic congenital heart disease (e.g., common atrium, atrioventricular septal defect, double-outlet right ventricle, often with pulmonary stenosis, interrupted IVC with azygos/hemiazygos continuation, bilateral superior vena cava).
    • Biliary atresia can occur.

Pathophysiology

• Mechanism: The exact embryological mechanism causing dextrocardia with isomerism is not fully understood, but it is believed to result from an arrest or abnormality in the normal left-right axis patterning during early embryonic development (weeks 3-8 of gestation). Disturbances in gene expression (e.g., genes involved in nodal signaling pathway like LEFTY, PITX2, NODAL, ZIC3, CFAP53) or cilia function (situs-specific ciliary immotility disorders) can lead to errors in the determination of organ laterality. Instead of developing distinct left and right sides, the body develops two "right" sides (right isomerism) or two "left" sides (left isomerism) regarding specific organs, leading to symmetrical duplication of structures that should be asymmetrical. The heart tube then undergoes abnormal looping, resulting in a right-sided heart (dextrocardia).
• Risk Factors:
  • Genetic predisposition: Family history of congenital heart disease or situs anomalies. Syndromes like heterotaxy syndrome are often associated.
  • Maternal diabetes (unclear direct link to isomerism, but a general risk factor for CHD).
  • Maternal exposure to certain teratogens (less clear for isomerism specifically).
  • Syndromic associations: Some cases are sporadic, others are part of broader syndromes.
• Protective Factors: None definitively identified, as this is a congenital developmental anomaly. Folic acid supplementation in pregnancy is generally recommended for neural tube defects, but its role in preventing situs anomalies is not established.

Clinical Presentation

Signs and Symptoms

Due to the high association with complex congenital heart disease, symptoms are primarily cardiac and vary significantly based on the specific cardiac anomalies present. - Cardinal Features: - Cyanosis: Often severe and early onset in RAI (due to pulmonary atresia/stenosis, total anomalous pulmonary venous return, common mixing at the atrial level). Less common or later onset in LAI. - Tachypnea/Dyspnea: Difficulty breathing, especially with feeding, due to heart failure or pulmonary overcirculation/hypoperfusion. - Failure to thrive: Poor weight gain. - Poor feeding: In infants, due to respiratory distress or fatigue. - Fatigue/Lethargy: In older children, reduced exercise tolerance. - Early Signs (Neonatal/Infancy): - Central cyanosis (blue discoloration of skin and mucous membranes). - Murmur (often loud and complex, but may be absent in severe outflow obstruction). - Jaundice (especially in polysplenia with biliary atresia). - Signs of congestive heart failure: hepatomegaly, peripheral edema, rales. - Recurrent infections (especially in asplenia due to immunodeficiency). - Advanced Signs (Untreated/Later Presentation): - Severe chronic cyanosis leading to clubbing and polycythemia. - Eisenmenger syndrome (in cases with large shunts and pulmonary hypertension). - Growth retardation. - Neurological complications (e.g., stroke from polycythemia, brain abscess from right-to-left shunt). - Atypical Presentations: - May present later in life if cardiac defects are less severe (e.g., only mild pulmonary stenosis or isolated systemic venous anomaly). - Presentation of malrotation or biliary atresia can overshadow cardiac symptoms initially.

Physical Examination

• Inspection:
  • Dextrocardia: Apex beat noted on the right side of the chest.
  • Cyanosis: Presence and degree (central, peripheral).
  • Respiratory distress: Tachypnea, retractions, nasal flaring.
  • Syndrome-specific features: No facial dysmorphism typically associated with isomerism itself, but may be part of broader syndromes.
• Palpation:
  • Apex beat: Palpable in the right 4th or 5th intercostal space, midclavicular line.
  • Thrills: May be palpable over the precordium, indicating significant murmurs.
  • Hepatomegaly: Sign of right-sided heart failure.
  • Pulses: Assessment of femoral and brachial pulses for coarctation or differential perfusion.
• Auscultation:
  • Heart sounds: S1, S2, presence of S3/S4. S2 may be single or narrowly split.
  • Murmurs: Variable, holosystolic (VSD, AVSD), systolic ejection (pulmonary stenosis), continuous (PDA). The location and radiation will differ due to dextrocardia.
  • Lungs: Rales, wheezes (signs of pulmonary congestion or infection).
• Special Tests (part of comprehensive exam/initial diagnosis):
  • Pulse oximetry: Low oxygen saturation, often unresponsive to oxygen in cyanotic heart disease.
  • Abdominal examination: Palpation for splenic integrity (absence in asplenia, multiple small spleens in polysplenia), liver position.

Diagnostic Approach

History Taking

• Key Questions:
  • Perinatal history: Pregnancy complications, maternal illnesses, medication use.
  • Neonatal course: Cyanosis at birth, respiratory distress, feeding difficulties, jaundice.
  • Developmental milestones: Growth and weight gain patterns.
  • Family history: Congenital heart disease, sudden infant death, situs anomalies.
  • Symptoms: Episodes of cyanosis, fainting, chest pain, exercise intolerance, recurrent infections.
• Red Flags:
  • Severe, persistent cyanosis in a neonate.
  • Rapid onset of respiratory distress.
  • Evidence of shock.
  • Persistent feeding difficulties and poor weight gain.
  • Recurrent severe infections (suggesting asplenia).

Laboratory Tests

• First-Line:
  • Complete Blood Count (CBC): To assess for polycythemia (chronic cyanosis) or anemia. Leukocytosis and thrombocytosis can occur in asplenia, but also anemia and thrombocytopenia in severe cases.
  • Arterial Blood Gas (ABG): To assess for hypoxia, hypercarbia, and metabolic acidosis.
  • Blood culture/sepsis workup: If fever or signs of overwhelming infection are present, especially in an infant with suspected asplenia.
  • Liver and renal function tests: To assess end-organ function.
• Confirmatory:
  • No single lab test confirms dextrocardia with isomerism. Diagnosis relies on imaging.
• Monitoring:
  • CBC: Regular monitoring for polycythemia (hematocrit >65%) in cyanotic patients, or anemia.
  • Coagulation studies: To assess for coagulopathy from polycythemia or liver dysfunction.
  • Electrolytes: To monitor for electrolyte imbalances, especially in heart failure.

Imaging

• Recommended:
  • Chest X-ray (CXR):
    • Dextrocardia: Heart shadow located in the right hemithorax.
    • Gastric bubble: Usually on the right side in dextrocardia.
    • Bronchial situs: Can offer clues to isomerism. In RAI, both main bronchi are short (similar to a normal right bronchus). In LAI, both main bronchi are long (similar to a normal left bronchus). This requires careful evaluation.
    • Pulmonary vascularity: Increased (shunt lesions) or decreased (pulmonary outflow obstruction).
  • Echocardiography (Echo): The cornerstone of diagnosis.
    • Confirms dextrocardia.
    • Identifies specific cardiac anomalies: common atrium/AVSD, TGA, pulmonary stenosis/atresia, systemic and pulmonary venous anomalies (e.g., bilateral SVC, interrupted IVC with azygos/hemiazygos continuation, total anomalous pulmonary venous return), ventricular morphology, outflow tract relationships.
    • Determines atrial situs by morphology of atrial appendages (morphological right atrium has a broad, triangular appendage; morphological left atrium has a narrow, finger-like appendage). This is critical for distinguishing RAI from LAI.
    • Assesses ventricular function and pulmonary pressures.
  • Abdominal Ultrasound:
    • Visualizes the abdominal situs: liver symmetry, position of great vessels, splenic status (absence in asplenia, multiple small spleens in polysplenia), bowel malrotation.
• Advanced:
  • Cardiac CT Angiography (CTA) or Cardiac MRI (CMRI):
    • Provides detailed 3D anatomical information, particularly useful for complex spatial relationships, anomalous venous return, pulmonary artery anatomy, and delineation of extracardiac anomalies.
    • Preferred over echocardiography for defining anomalous venous connections and complex arch anomalies, especially pre-operatively.
    • CMRI is helpful for functional assessment and tissue characterization.
  • Fetal Echocardiography:
    • Can diagnose dextrocardia with isomerism prenatally, typically in the second trimester (18-22 weeks gestation). Allows for antenatal counseling and planning for postnatal management.
  • Angiography/Cardiac Catheterization:
    • Diagnostic and therapeutic intervention: Used to define complex anatomy not fully delineated by non-invasive imaging, measure pressures, and assess pulmonary vascular resistance. Can be used for balloon atrial septostomy or stent placement.

Management

Acute Management

Depends entirely on the severity of the associated cardiac lesions. - Immediate (Neonatal Crisis): - Establish airway and breathing: May require mechanical ventilation. - Stabilization of circulation: - Prostaglandin E1 (PGE1): Initiate for ductal-dependent pulmonary or systemic blood flow (e.g., pulmonary atresia, severe pulmonary stenosis, severe coarctation, interrupted aortic arch). Dosage typically 0.05-0.1 mcg/kg/min IV, titrated to effect. - Volume resuscitation: For hypotension. - Inotropic support: Dopamine, dobutamine, or milrinone for myocardial dysfunction. - Manage hypoxemia: Supplemental oxygen (use cautiously in situations with pulmonary overcirculation), manage ventilatory support. - Blood glucose monitoring: Hypoglycemia is common in sick neonates. - Stabilization: - Surgical consultation: Urgent consultation with congenital cardiac surgeon and pediatric cardiology. - Infection prophylaxis: For asplenia syndrome, prompt initiation of antibiotics for any signs of infection. Prophylactic antibiotics (e.g., Penicillin V) start early after diagnosis. - Fluid and electrolyte management: Careful monitoring to avoid fluid overload or dehydration. - Emergency: - Balloon Atrial Septostomy (BAS): Performed via cardiac catheterization if there is restricted interatrial communication in common atrium with parallel circulation, especially in TGA with intact ventricular septum and severe cyanosis, to improve mixing. - Surgical palliation: For severe cardiac lesions, immediate surgical intervention may be required (e.g., Blalock-Taussig shunt for pulmonary stenosis/atresia).

Chronic Management

Highly individualized based on the specific cardiac anatomy and physiology. The goal is often staged palliation towards a Fontan circulation. - Pharmacological: - Diuretics: Furosemide (1-2 mg/kg/dose orally BID/TID) for heart failure. - ACE inhibitors: Captopril (0.1-0.5 mg/kg/dose orally TID) or enalapril (0.1 mg/kg/dose BID) for ventricular dysfunction or systemic hypertension. - Digoxin: In select cases of heart failure (dose individualized, typically 5-10 mcg/kg/day in children). - Prophylactic antibiotics: For asplenia, penicillin V (e.g., 125 mg orally BID for children < 5 years, 250 mg orally BID for children ≥ 5 years) should be continued lifelong. Pneumococcal vaccine series and annual influenza vaccine strongly recommended. - Anticoagulation: For patients post-Fontan procedure (aspirin, warfarin). - Non-pharmacological: - Nutritional support: High-calorie formula for infants with failure to thrive. May require nasogastric or gastrostomy tube feeding. - Activity restriction: Based on cardiac reserve and the specific lesion. - Dental prophylaxis: For endocarditis prevention in high-risk groups (e.g., uncorrected cyanotic CHD, prosthetic valves, post-repair with residual defects). - Monitoring: - Regular cardiology follow-up: Lifelong. Includes clinical assessment, echocardiograms (every 6-12 months, or as needed), ECGs. - Imaging: Periodic CT/MRI scans to assess evolving anatomy, especially pulmonary arteries and venous return, and Fontan circuit integrity. - Laboratory studies: CBC (polycythemia, anemia), electrolytes, liver/renal function, PT/INR if on anticoagulation. - Developmental assessment: Early intervention services if needed. - Infectious disease follow-up: For asplenia patients.

Treatment Algorithms

There is no single algorithm for dextrocardia with isomerism due to the vast heterogeneity of associated defects. Management typically follows algorithms for specific types of complex congenital heart disease (e.g., hypoplastic left heart syndrome, common atrium) often involving staged palliation.

• For Cyanotic Cardiac Defects (e.g., RAI with pulmonary atresia/stenosis):

  1. Neonatal Stabilization: PGE1, ventilation, inotropes.
  2. Stage 1 (Neonatal/Infancy):
     • Systemic-to-pulmonary shunt (e.g., Blalock-Taussig shunt): To ensure adequate pulmonary blood flow in cases of pulmonary outflow obstruction.
     • Pulmonary artery banding: For pulmonary overcirculation (if ventricular septal defect is present).
     • Atrial septectomy/septostomy: If there is inadequate interatrial mixing.
  3. Stage 2 (Bidirectional Glenn/Hemi-Fontan, 4-12 months): If suitable candidates, superior vena cava connected to the pulmonary artery.
  4. Stage 3 (Fontan Completion, 2-5 years): Inferior vena cava connected to the pulmonary artery, creating a total cavopulmonary connection.

• For Acyanotic/Mildly Cyanotic Defects (e.g., LAI with interrupted IVC, AVSD):

  1. Initial management: Control heart failure symptoms with medications.
  2. Surgical repair:
     • Atrioventricular Septal Defect (AVSD) repair: Patch closure of atrial and ventricular components, repair of common AV valve (typically 3-6 months of age).
     • Correction of venous anomalies: If clinically significant (e.g., baffle of bilateral SVC), though often not requiring intervention for interrupted IVC with azygos.
     • Management of pulmonary stenosis if present.

Complications

• Common:
  • Congestive heart failure: Due to shunt lesions, ventricular dysfunction.
  • Cyanosis and hypoxemia: Leading to polycythemia, clubbing, exercise intolerance.
  • Pulmonary hypertension: Especially in uncorrected shunt lesions.
  • Arrhythmias: Common in patients with common atrium/AVSD and post-operative Fontan patients (atrial flutter, sick sinus syndrome).
• Serious:
  • Infections: Especially in asplenia (sepsis, meningitis, pneumonias) due to encapsulated bacteria (e.g., S. pneumoniae, H. influenzae, N. meningitidis).
  • Thromboembolism: Increased risk in polycythemia and post-Fontan.
  • Sudden cardiac death: From arrhythmias, pulmonary hypertensive crises.
  • Protein-losing enteropathy/Plastic bronchitis: Post-Fontan complications.
  • Liver dysfunction: Post-Fontan.
• Long-term:
  • Developmental delay: Due to chronic hypoxemia or prolonged hospitalizations.
  • Neurocognitive impairment: Higher risk than general population.
  • Renal dysfunction: Chronic.
  • End-stage heart failure/transplant: Eventual outcome for a subset of single ventricle patients.

Prognosis

• Factors:
  • Specific cardiac anatomy: The most important determinant. RAI with extreme cyanotic lesions typically has a worse prognosis than LAI.
  • Presence/absence of spleen: Asplenia confers greatly increased risk of lethal infection.
  • Pulmonary vascular disease: Development of irreversible pulmonary hypertension significantly worsens prognosis.
  • Success of surgical palliation: Especially progression to successful Fontan completion.
  • Arrhythmias: Significant impact on quality of life and survival.
  • Associated non-cardiac anomalies: Such as biliary atresia, intestinal malrotation.
• Survival:
  • Overall survival for situs ambiguus with congenital heart disease has significantly improved with advancements in surgical techniques, ICU care, and medical management.
  • For RAI (asplenia syndrome), historical data showed very poor survival (e.g., <20-30% at 1 year without surgical intervention). With current aggressive management, 5-year survival rates can approach 50-70% in centers of excellence, but significant morbidity persists.
  • For LAI (polysplenia syndrome), survival is generally better than RAI, often due to less severe cardiac lesions and absence of asplenia. 5-year survival rates can be >70-80%.
  • Long-term survival into adulthood is now more common, but patients face lifelong challenges.
• Quality of Life:
  • Variable, depending on residual cardiac function, exercise capacity, and freedom from complications.
  • Patients often experience reduced exercise tolerance and may require ongoing medical care and potentially future cardiac interventions (e.g., re-interventions, transplant).
  • Neurodevelopmental outcomes require close monitoring and support.

Prevention

• Primary:
  • Currently, no specific primary prevention measures for dextrocardia with isomerism due to its genetic/embryological origin.
  • Genetic counseling for families with a history of situs anomalies may be considered.
• Secondary:
  • Early prenatal diagnosis: Fetal echocardiography is crucial for early detection, allowing for counseling, delivery planning at specialized centers, and preparation for postnatal management.
  • Newborn screening: Pulse oximetry screening can detect critical congenital heart disease, though specific situs anomalies require further imaging.
• Tertiary:
  • Aggressive cardiac management: Timely surgical or catheter-based interventions to prevent progression of heart failure, pulmonary hypertension, and cyanosis.
  • Infection prophylaxis: Lifelong antibiotic prophylaxis and immunizations against encapsulated bacteria for patients with asplenia.
  • Anticoagulation: Appropriate initiation and monitoring to prevent thromboembolic events, especially post-Fontan.
  • Regular follow-up: Strict adherence to cardiology follow-up schedules.

Special Populations

• Pediatric:
  • Neonates/Infants: Primary focus on immediate stabilization, diagnosis through echocardiography, and early surgical palliation for life-threatening lesions. Nutritional support is critical.
  • Children: Continued growth and developmental monitoring. Gradual progression through staged palliation. Management of schooling and activity levels.
• Geriatric:
  • Rare, as many individuals with severe isomerism-associated CHD do not reach advanced age.
  • Management focuses on complications of long-standing CHD (e.g., heart failure, arrhythmias, pulmonary hypertension, chronic kidney disease) and potential Fontan failures (e.g., Fontan-associated liver disease, protein-losing enteropathy).
• Pregnancy:
  • Pregnancy in women with dextrocardia and isomerism (especially single ventricle physiology post-Fontan) is high-risk. Requires multidisciplinary care involving high-risk obstetrics and adult congenital heart disease specialists.
  • Risks include cardiac decompensation, arrhythmias, thromboembolism, and increased risk of neonatal congenital heart disease. Counseling about risks to mother and fetus is essential.
• Comorbidities:
  • Asplenia: Requires strict adherence to immunizations (pneumococcal, H. influenzae B, meningococcal) and lifelong antibiotic prophylaxis. Education on symptom recognition of overwhelming sepsis is crucial.
  • Intestinal malrotation: Often asymptomatic but can present with life-threatening volvulus. Surgical correction may be considered, but often deferred due to cardiac risks.
  • Biliary atresia: In some LAI cases. Requires Kasai portoenterostomy.
  • Renal anomalies, genitourinary anomalies: Must be evaluated as part of a comprehensive assessment.

Clinical Pearls

• Diagnostic:
  • Always suspect isomerism in any infant with dextrocardia and complex congenital heart disease.
  • Echocardiography is the initial diagnostic tool, but always confirm atrial situs by appendage morphology. Visualizing spleen and bronchial situs is also crucial.
  • Don't mistake dextroversion (heart is in the right chest but apex points left or midline, with normal abdominal situs) for dextrocardia with isomerism. Dextrocardia means apex points right.
  • Pulmonary and systemic venous anomalies are highly variable in isomerism and require careful delineation by advanced imaging (CTA/MRI) before surgery.
• Treatment:
  • No "one-size-fits-all" approach. Management is highly individualized.
  • Asplenic patients are critically vulnerable to infection. Educate families on fever management and provide clear "sick protocols."
  • Staged palliation for single ventricle physiology is complex and carries cumulative risks. Optimize nutritional status and manage interstage period carefully.
  • Arrhythmias are common and can significantly impact hemodynamics. Aggressive management is warranted.
• Pitfalls:
  • Missing the diagnosis of asplenia: Can lead to fatal sepsis. Always evaluate splenic status.
  • Underestimating the complexity of venous return: Incomplete understanding of systemic and pulmonary venous anomalies can lead to surgical challenges and complications.
  • Failure to appreciate the unique physiology of single ventricle palliation: Patients are always more fragile and require expert management.
  • Delaying intervention: Timely intervention is critical for ductal-dependent lesions or severe heart failure.

Recent Updates

• Guidelines: The 2018 American Heart Association/American College of Cardiology (AHA/ACC) Guidelines for the Management of Adults With Congenital Heart Disease (ACHD) and pediatric cardiology guidelines emphasize lifelong follow-up for complex CHD, including those with isomerism, often in specialized ACHD centers.
• Evidence:
  • Continued research into the genetic basis of situs ambiguus and heterotaxy syndrome is identifying new genes and pathways involved in left-right axis determination, potentially opening avenues for future targeted therapies or improved risk assessment.
  • Advances in surgical techniques for single ventricle palliation have improved outcomes, but ongoing research focuses on reducing long-term complications of the Fontan circulation (e.g., liver disease, protein-losing enteropathy, thrombosis).
  • Improved neurodevelopmental outcomes research highlights cognitive and behavioral challenges in this population, advocating for early intervention and support services.
• Controversies:
  • Timing and type of initial repair: Debates continue regarding the optimal timing and specific conduits used for systemic-to-pulmonary shunts, pulmonary artery banding, and the decision-making process for biventricular vs. univentricular repair when functionally feasible.
  • Prevention and management of Fontan complications: Optimal anticoagulation strategies, surveillance for Fontan-associated liver disease, and management of protein-losing enteropathy remain areas of active research and variability in practice.

Key References

• Guidelines:
  • Valente AM, et al. 2018 AHA/ACC Guideline for the Management of Adults with Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019;139(25):e1-e85.
  • Task Force on the Management of Congenital Heart Disease in Adults, European Society of Cardiology (ESC). ESC Guidelines for the management of adult congenital heart disease. Eur Heart J. 2010;31(23):2915-2957.
• Studies:
  • Jacobs JP, et al. The nomenclature of situs anomalies. Images in Cardiovascular Medicine. Circulation. 2007;116:855-866.
  • Ticho BS, et al. Human single left-right axis malformations. Am J Med Genet C Semin Med Genet. 2005;135C(1):60-70.
  • Phoon CKL. The embryology of left/right asymmetry disorders. Semin Roentgenol. 2006;41(3):203-210.
• Reviews:
  • Lo CWM, et al. Situs inversus and heterotaxy. Am J Med Genet C Semin Med Genet. 2005;135C(1):16-23.
  • Penny DJ, et al. Atlas of Cardiac Anatomy and Congenital Heart Disease. Blackwell Publishing, 2013.
  • Anderson RH, et al. The morphogenesis of the heart in atrioventricular septal defect. J Anat. 2014;225(1):74-88.

---

Disclaimer: This information is provided for educational and informational purposes only, and does not constitute medical advice. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition. Clinical judgment must always be exercised in the context of individual patient circumstances. Drug dosages and treatment regimens are subject to change and should always be verified with current prescribing information and local protocols.